Deep And Durable Responses With Selinexor, Daratumumab, And Dexamethasome (Sdd) In Patients With Multiple Myeloma (Mm) Previously Exposed To Proteasome Inhibitors And Immunomodulatory Drugs: Results Of Phase 1b Study Of Sdd

BLOOD(2018)

引用 11|浏览41
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要